Secondary Logo

Journal Logo

Review Articles

Anesthesia and Cognitive Outcome in Elderly Patients: A Narrative Viewpoint

Cottrell, James E. MD; Hartung, John PhD

Author Information
Journal of Neurosurgical Anesthesiology: January 2020 - Volume 32 - Issue 1 - p 9-17
doi: 10.1097/ANA.0000000000000640
  • Open


The assumption that anesthetics and sedatives are entirely reversible neurotoxins is probably true for most patients between 3 and 60 years old. However, seniors are at greater risk because systems that once enabled full recovery have diminishing capacity. The older brain has less cognitive reserve—less resilience to neurological challenges. Oxidative phosphorylation does not work as well. We acquire mutations that can alter outcomes. We accumulate proteins with prion-like domains.1 Genetic alleles that were silent when we were young manifest themselves as we age, and we face free radical buildup with reduced levels of scavengers. All these dreary realities probably contribute to Kline et al’s2 finding that “Elderly subjects after surgery experienced an increased rate of brain atrophy” and, as found by Silbert et al,3 subjects with mild cognitive impairment suffered greater deleterious cognitive effects after surgery and anesthesia.


In 1955, Bedford4 published “Adverse cerebral effects of anaesthesia on old people.” He reviewed 1193 patients over 50 years of age who had received general anesthesia. Mental deterioration in 10% of patients appeared to be long-term or permanent—a figure that concurs with subsequent findings. Bedford concluded that cognitive decline is related to anesthetic agents and hypotension. He recommended that “Operations on elderly people should be confined to unequivocally necessary cases” and that “postoperative medication should not be a routine matter.” The next major study to report postoperative cognitive dysfunction (POCD) skips ahead 43 years to 1998—the first International Study of Postoperative Cognitive Dysfunction (ISPOCD).5 In noncardiac patients more than 59 years old, the incidence of cognitive dysfunction 1 week after surgery was 22% higher than in age-matched controls and 7% higher 3 months after surgery (P<0.004 for both) with 10% of patients evidencing POCD. So the ISPOCD results echoed Bedford’s finding at a longer postoperative interval. Increasing age, duration of anesthesia, lesser education, a second operation, postoperative infection, and respiratory complications were risk factors for early POCD. However, under a circumstance of significantly reduced statistical power owing to a 22% loss of follow-up at 3 months, among the risk factors that were significant in the early postoperative period, only age remained statistically significant.

Monk et al6 found that 12.7% of elderly (older than 59 y old) noncardiac patients had POCD 3 months after surgery—again within a narrow confidence interval around Bedford’s 1955 report. Corroborating earlier work,7 Monk’s study also found a substantial relationship between POCD and death within 1 year of surgery. Independent risk factors for sustained POCD included greater age, less education, POCD at hospital discharge, and a history of stroke without apparent residual damage. Notably, Monk and colleagues’ 2008 study did not find duration of anesthesia to be a risk factor. However, the risk of a false-negative conclusion is high in that regard, because the sample size of elderly patients at the 3-month measurement was even smaller (308 with 39 POCD patients6) than in the ISPOCD study (901 with 91 POCD patients5). The longest follow-up study of POCD patients (median=8.5 y) was published by the ISPOCD group in 2009: “Cognitive dysfunction after noncardiac surgery was associated with increased mortality, risk of leaving the labor market prematurely, and dependency on social transfer payments.”8


Newman and colleagues found POCD in 53% of coronary artery bypass graft (CABG) patients at discharge and in 36% of patients 6 weeks later. That proportion went down to 24% six months after surgery, but came back up to 42% five years after surgery—a pattern of early improvement followed by subsequent decline that was predicted by POCD at discharge.9 Evered et al10 subsequently found strong associations between POCD at 12 months after CABG surgery and death within 10 years, and a dramatically increased incidence of dementia 7.5 years after CABG surgery.

The factors that cause decline in cognitive capacity among non-CABG patients also affect CABG patients. However, some of those potential risk factors, like duration of exposure to anesthetics, can be masked by damage done to CABG patients from increased liability to cerebral emboli, cerebral ischemia during reperfusion, and overwarming after bypass.11 In this regard, Hofland et al’s12 finding that xenon anesthesia reduces cardiac troponin release after CABG surgery adds incentive to further explore xenon’s protective attributes.13


On-pump Versus Off-pump

Does on-pump versus off-pump bypass make a neurocognitive difference? Several trials failed to detect a neurocognitive advantage for off-pump patients.14–16 Although Shroyer et al14 did not find a statistically significant difference across their composite test battery, they did find a significant difference on one important test in favor of off-pump bypass, suggesting the possibility of a false-negative conclusion. The 1-year follow-up from both the CABG Off or On Pump Revascularization Study (CORONARY)15 and the German Off-Pump Coronary Artery Bypass Grafting in Elderly Patients study16 failed to find a statistically significant advantage of off-pump bypass. Statistical significance aside, both investigations found a lower incidence of stroke in off-pump patients, and a meta-analysis of 100 investigations covering 19,192 patients by Kowalewski et al17 found a 28% reduction in stroke for off-pump bypass (P<0.009). So we are left wondering how patients who experience more strokes (on-pump patients) did not evidence statistically significantly worse neurocognitive outcome. One reason is that in the CORONARY study, some surgeons took the liberty of performing off-pump surgery on 102 patients who had been randomly assigned to on-pump surgery because those patients had calcification of the aorta. In the intention-to-treat analysis, those patients’ results were analyzed as if they had on-pump surgery.18 These profound protocol violations were accompanied by patient-selected, as distinct from randomly selected, inclusion in neurocognitive testing.15 We have argued that intention-to-treat analysis should always be accompanied by per-protocol analysis,19 and calculating a “P”-value for nonrandom samples makes no sense.20 In this case, “absence of evidence is not evidence of absence,”21 and unless strokes do not have neurocognitive consequences (as distinct from detected neurocognitive consequences), our appraisal is that the CORONARY study should be disregarded.

Puskas and colleagues found that “After a mean of 7.5 years of follow-up, patients under-going off-pump coronary artery bypass performed better than those undergoing (on-pump) cardiopulmonary bypass in several neuropsychological domains.”22 In what amounts to a serendipitous positive-control study, Li and colleagues found that preconditioning with hyperbaric oxygen (HBO) reduced markers of cerebral injury in patients undergoing on-pump bypass but not in patients having off-pump bypass, reasoning that “the protective effects of HBO preconditioning may only manifest when there is a relatively severe injury, such as an on-pump procedure and not in off-pump CABG surgery patients.”23 Subsequently, Brewer and coauthors found more postoperative complications, including permanent strokes, in 3898 on-pump patients who were baseline-matched to 3898 off-pump patients.24 More recently, Kok et al’s25 prospective study found substantially less POCD 3 months after CABG surgery in patients randomized to off-pump bypass. The primary mechanism for these differences is almost certainly the several-fold increase in cerebral microemboli found in on-pump patients, which correlates with “a significant relative reduction in prefrontal activation.”26

Less direct evidence came from a study of >16,000 patients in whom a greater incidence of delirium occurred after on-pump cardiopulmonary bypass, with duration of surgery (and so anesthesia) as a significant risk factor.27 Although those patients were not followed up for POCD, Girard et al28 found that in “mechanically ventilated medical intensive care unit patients, duration of delirium (which is potentially modifiable) was independently associated with long-term [12 mo] cognitive impairment” and Morandi et al29 found that “delirium duration in the intensive care unit was associated with white matter disruption at both discharge and 3 months later, with worse cognitive scores up to 12 months after discharge.” In a prospective study of 225 CABG patients, Saczynski et al30 found that “Delirium is associated with a significant decline in cognitive ability during the first year after cardiac surgery,” and in 263 Alzheimer disease (AD) patients, Gross et al31 concluded that “Delirium is highly prevalent among persons with AD who are hospitalized and is associated with an increased rate of cognitive deterioration that is maintained for up to 5 years.” Neufeld et al32 found that postoperative delirium in the postanesthesia care unit “is associated with subsequent delirium on the ward … with a decline in cognitive function and increased institutionalization at hospital discharge.” Mangusan et al33 also found that “Patients with postoperative delirium had significantly longer stays … and greater prevalence of falls … than did patients without delirium. Patients with delirium also had a significantly greater likelihood for discharge to a nursing facility … and need for home health services if discharged to home and a significantly higher need for inpatient physical therapy [all P<0.001].”

In 560 patients age 70 or more without dementia who underwent major surgery, Inouye et al34 found that cognitive decline was accelerated among patients who suffered postoperative delirium versus those without delirium. Although Daiello et al35 recently concluded that “Postoperative delirium and postoperative cognitive dysfunction may be distinct manifestations of perioperative neurocognitive deficits,” as described in the limitations paragraph of their publication, “our negative findings were attributable in part to insufficient sample sizes.” Between that statistical power concern,21 inserting of much “imputed data,” a brief follow-up period, and admission that their retrospective study “was not designed to investigate associations between postoperative delirium, our construct of postoperative cognitive dysfunction, and long-term cognitive recovery,” Daiello and colleagues conclusion remains trumped by Inouye et al’s34 finding from the same database, that “… described the long-term consequences of postoperative delirium in the Successful Aging after Elective Surgery cohort and found that delirium was associated with a 2.8-fold increase in the rate of cognitive decline over three years.”35 That finding was recently supported by Sprung et al’s36 finding that “Elderly patients who have not been diagnosed with MCI [mild cognitive impairment] or dementia [N=1667] but experience POD [postoperative delirium] are more likely to be diagnosed subsequently with MCI or dementia.” Royse et al37 found that patients who experienced delirium after cardiac surgery were less likely to recover cognitive capacity 6 months postoperatively with that finding recently extended by Brown et al38 in reference to processing speed (an important basic resource of intelligence39) 1 year postoperatively.

Perhaps most telling, Vasunilashorn et al40 recently found a dose-response curve between delirium severity and rate of cognitive decline on serial neuropsychological testing administered over three years. Clearly, a relationship between depression, sedation, delirium, poor neurological outcome, and POCD should not be discounted,27–34,36–41 such that off-pump patients may be at lesser risk for POCD.


Inflammation caused by surgical trauma may also aggravate POCD.42,43 Evidence that the association is causal comes from Vom Berg et al’s44 finding that intracerebroventricular delivery of anti-p40, an inhibitor of inflammatory signaling, significantly reduces the concentration of amyloid β (Aβ) and reverses cognitive deficits in aged Alzheimer mice. We know about the upregulation of IL-1, and this in turn can affect anesthetic receptors. The ensuing cascade of events ultimately affects the anesthetic GABA and NMDA receptors and increases production of Aβ … and we know that soluble oligomers of Aβ, even in nondemented patients, associate with cognitive problems. Genetic predispositions are another aggravating factor. Mathew and coauthors have shown the contribution of P-selectin and C-reactive protein alleles to cognitive decline caused by inflammation after cardiac surgery,45 and a link between the PlA2 allele of platelet GPIIIa with more severe neurocognitive decline after cardiopulmonary bypass.46

General Anesthetics

Are anesthetics aggravating factors? If so, are some more toxic than others? Xie’s group found greater cognitive decline 1 week after surgery in patients who received spinal anesthesia with desflurane versus spinal anesthesia with isoflurane or spinal anesthesia alone.47 Ishii et al48 found that propofol is associated with less postoperative delirium compared with sevoflurane in elderly patients, and Geng et al49 found that propofol is associated with less short-term POCD than sevoflurane and isoflurane following laparoscopic cholecystectomy in elderly patients. Examining autopsy brain tissue, Crary and coauthors found that PKMzeta, an atypical protein kinase C isoform, accumulates in the neurofibrillary tangles of Alzheimer patients, but not in control patients.50 Given the findings of Eckenhoff’s group and others,51–59 one wonders whether anesthetics might increase this tangling in both AD and non-AD patients. Our laboratory is continuing its investigation of the effect of anesthetics on PKMzeta in the adult mouse hippocampus.60

Anesthesia and Neurodegenerative Diseases

Do anesthetics aggravate neurodegenerative diseases? Hydrophobic cavities keep sticky proteins from becoming irreversibly glued together. Unfortunately, molecules of inhalational anesthetics can fill those cavities and reduce the amount of energy required to maintain protein assembly.51 This anesthesia-facilitated disinhibition of protein binding helps monomers aggregate into oligomers, and if those monomers are Aβ, the resulting oligomerization can lead to protofibrils that are small enough to diffuse into neurons and large enough to be neurotoxic. Soluble Aβ oligomers52 and alpha-synuclein53 appear to contribute to the neurodegeneration characterized by Alzheimer in the early 20th century. About 14 million Americans are projected to have AD by the middle of the 21st century. Many of them will need to be anesthetized, and many of those will have been anesthetized before they became demented.

The role of inhalational anesthetics in the above scenario has been verified in vitro by a decade of work from Eckenhoff and coauthors,54 and is supported in vivo by mouse models.55 In addition to the Aβ-anesthesia connection, Xie’s group has utilized human neuroglioma cell cultures to add anesthesia-induced apoptosis as a factor contributing to AD,56,57 and they have found that isoflurane, but not desflurane, degrades mitochondrial function and impairs learning and memory in mice.58 Do the rodent and cell culture findings apply to humans? Eckenhoff’s group reported that the total-tau/Aβ (1-42) ratio in cerebrospinal fluid—the only biomarker validated for use in the diagnosis of AD by the Alzheimer Disease Neuroimaging Initiative (ADNI)—elevates during surgery and anesthesia in healthy patients and rises above ADNI’s threshold for mild cognitive impairment within 48 hours.59 In an article entitled “Coronary artery bypass surgery provokes Alzheimer’s disease-like changes in the cerebrospinal fluid,” Palotás and colleagues found an increased tau/Aβ ratio in patients 6 months after surgery.61

Early results from retrospective studies on a possible association between anesthetic exposure and AD were unsettling but inconclusive.62 Now 2 large studies have found substantial evidence. Matching for age and sex, Pin-Liang Chen and coauthors compared 1539 patients who had never been anesthetized to 661 patients who had been anesthetized after age 50. After adjustment for comorbidities, the patients exposed to anesthesia had a nearly 2-fold greater incidence of dementia (P<0.001).63 Comparing 5345 patients recently diagnosed with dementia to 21,380 age and sex-matched individuals without dementia, Chia-Wen Chen and colleagues found a substantially higher incidence of anesthesia exposure, in a dose-response relationship, among the demented patients (P<0.0001).64 Benzodiazepine use may also be a substantive risk factor with a “stronger association observed for long-term exposures.”65 Of course, surgery involves much more than administration of anesthetics and sedatives, and it is becoming increasingly difficult to rule out iatrogenic transmission of AD,66 especially during neurosurgery.67


Deeper Versus Lighter Anesthesia

Brown et al68 found that elderly patients with serious comorbidities receiving light sedation (bispectral index [BIS] >80) during spinal anesthesia for hip surgery had reduced 1-year mortality compared with patients who received deep sedation (BIS≈50). Ancelin et al69 found that “Adding sedation to peridural anesthesia led to a decline in verbal secondary memory” and Sieber et al70 found that lighter sedation during spine surgery led to less delirium, with the Sieber group’s more recent study finding that “heavier versus lighter sedation levels doubled the risk of delirium” in patients without comorbidities.71 Again, there are empirical and neuropathologic reasons to suspect a link between delirium, deep sedation, poor neurological outcome, and POCD.27–34,36–41

Indeed, presaged by results from a pilot study by Ballard et al,72 an investigation by the Cognitive Dysfunction after Anesthesia (CODA) Trial of 921 elderly patients undergoing major noncardiac surgery found that patients with a median BIS of 53 experienced less delirium and had less POCD 3 months after surgery than a control group maintained at a median BIS of 3673 (Table 1)—a result that accords well with Fritz and coauthors’ findings,74,75 and meta-analyses by Punjasawadwong et al76 and MacKenzie et al77 which support the hypothesis that intraoperative electroencephalogram (EEG) suppression predicts postoperative delirium. As put by Green and colleagues, “The important point about this trial [the CODA trial] is that the investigators were able to maintain an average BIS of 53 in the intervention group versus 36 in the control group. This not only resulted in a significant decrease in POCD, but also in postoperative delirium, which we acknowledge is a cause of significant postoperative morbidity … As our population ages, we can no longer be complacent about how our intraoperative management may affect postoperative outcome.”78

Postoperative Cognitive Outcomes

In sharp contrast to preceding meta-analyses,76,77 the Electroencephalography Guidance of Anesthesia to Alleviate Geriatric Syndromes (ENGAGES) Trial concluded that “electroencephalography-guided anesthetic administration” does “not decrease the incidence of postoperative delirium79—despite presenting data that confound that conclusion.80 Close examination of the ENGAGES Trial’s figure 279 reveals that within its usual care group, time spent in EEG suppression was 5-fold greater in patients who experienced delirium (∼48 vs. ∼10 min, n=594, Fig. 1), and time spent with BIS<40 was 2-fold greater in the delirium group (∼100 vs. ∼49 min, n=575, Fig. 1). Given the sample sizes involved, it would be surprising if those median differences are not statistically significant, but calculation would require raw data with statistical significance best assessed by a bootstrapping method,81 as distinct from Mann-Whitney U tests.82 Statistical significance aside, absolute differences of that magnitude in the direction of a relationship between EEG suppression and BIS<40 with delirium, are an objectionable basis for concluding the absence of a relationship.21

The ENGAGES Trial’s Usual Care Group. The median values depicted can be estimated by enlarging the ENGAGES Trial’s figure 2 by 1600%, at which point (at least on our computer screens), each millimeter equals 1 minute. The numbers 10, 48, 49 and 100 are estimates of the medians depicted by bold horizontal lines. Adapted from Wildes et al79 with permission. Adaptations are themselves works protected by copyright. So in order to publish this adaptation, authorization must be obtained both from the owner of the copyright in the original work and from the owner of copyright in the translation or adaptation.

At face value, the EEG data in the ENGAGES’s trial’s usual care group support, rather than contradict, the Avidan group’s earlier finding that “Intraoperative Electroencephalogram suppression Predicts Postoperative Delirium.”72,73 Maintaining that conclusion while also concluding that “electroencephalography-guided anesthetic administration” does “not decrease the incidence of postoperative delirium77 requires accepting the hypothesis that EEG suppression correlates with delirium while simultaneously accepting the bemusing null hypothesis that low BIS does not correlate with EEG suppression … despite substantial evidence to the contrary74,75 and the fact that BIS is derived from EEG.

If EEG suppression and BIS<40 predict delirium, why did the ENGAGES Trial79 not find a difference in the incidence of delirium between its usual care group and its BIS-guided group? Two factors may have had played a role, the first made evident by data, with the second based on speculation. The data-based factor is that the trial compared groups that received deep versus deeper anesthesia. That is, half of the patients in The ENGAGES Trial’s BIS-guided group experienced BIS<40 for more than half an hour, contrary to the expectation that BIS guidance should reduce the frequency and duration of BIS<40 to incidental amounts. Severe adverse effects of BIS<40 have been reported at a threshold of BIS<40 for as brief as 5 minutes.81 If there is a threshold effect for an association between low BIS and delirium in patients that “appear to exhibit a phenotype of anaesthetic sensitivity, which might predispose them to adverse cognitive outcomes,”73 with age and comorbidity (both high in the ENGAGES Trial) reducing that threshold to any amount less than half an hour, there would be no difference in the incidence of delirium between a group with median BIS<40 for 32 minutes and a group with BIS<40 for 60 minutes (ie, between the ENGAGES Trial’s BIS-guided group and its usual care group).

In reference to time spent in EEG suppression by patients in The ENGAGES Trial, Ackland and Pryor wrote, “Previous observational data from the same investigators reported that the duration of electroencephalogram suppression >4.5 minutes was associated with markedly higher incidence of delirium (∼45% vs. 25% incidence of delirium in individuals with <4.4 min of burst suppression). Moreover, no further increase in incidence of delirium was evident with more than three-fold longer episodes. The ENGAGES79 intervention reduced the median cumulative time spent with electroencephalogram suppression (7 min in EEG guided vs. 13 min in control group; difference: −6.0; 95% CI: −9.9 to −2.1). However, the duration for both groups in ENGAGES breached the threshold values found previously to be associated with a marked increased risk of delirium. These data suggest that, unless pilot data using the intervention limited burst suppression to <4 minutes, the likelihood of ENGAGES showing a reduction in delirium was quite small.”84

Our speculative conjecture is that there is a difference between a bonafide usual care group (a group that is not connected to a BIS monitor) and a group of patients who are connected to a BIS monitor by an anesthesia team that makes sure the monitor is properly calibrated, but then masks the BIS readout so it cannot be seen. That arrangement generates competition between clinical judgment aided by a machine and clinical judgment not aided by a machine.85 If BIS-blinded clinicians had more than a decade of practice competing against BIS-guided clinicians,86–92 it is less surprising to find that the ENGAGES Trial’s BIS-blinded teams achieved almost exactly the same duration of anesthesia (264 vs. 264.5 min), almost exactly the same MAP (79.6 vs. 81.2 mm Hg), and the same number of patients with median cumulative time at MAP<60 mm Hg (7/618 vs. 7/614) as the trial’s BIS-guided teams.79

Put differently in an editorial entitled “Power of Negative Thinking,” citing Karl Popper, Avidan and Wildes wrote “As stated by Popper, ‘For if we are uncritical we shall always find what we want: we shall look for, and find, confirmations, and we shall look away from, and not see, whatever might be dangerous to our pet theories.’”93 Although pet theories are more often satisfied by positive outcomes, when they are satisfied by negative outcomes (outcomes of no difference), Popper’s admonition still applies. It is worth noting that in 10 of the ENGAGES Trial’s usual care group cases, the anesthesiologists violated protocol by pulling the mask off the BIS monitor so that they, and their patients, could have the benefit of the BIS readout.79 The ENGAGES CANADA94 results may provide further insight into these issues.

The ENGAGES Trial found that 4 patients in its BIS-guided group died within 30 days of surgery compared with 19 patient deaths in the usual care group79 (P<0.0024, 2-way Fisher Exact Test). As noted by Abbott and Pearse,95 that “lower 30-day mortality rate observed among the EEG-guided group is intriguing and appears consistent with the findings of the secondary analysis of a 2010 randomized trial83 … the difference in mortality may plausibly be related to an increased incidence of cardiovascular instability in the usual care group as a result of higher anesthetic doses. Although the reported incidence of intraoperative hypotension duration was similar in each group, patients in the usual care group received significantly higher doses of phenylephrine, indicating a more frequent need to manage episodes of arterial hypotension during the surgical procedure.79 There is robust evidence to suggest that more episodes of hypotension would lead to an increased incidence of perioperative myocardial injury that might explain the higher mortality rate.”96–99

Indeed, and if clinicians appreciate BIS monitoring as a tool that enhances their clinical judgment, as distinct from worrying that BIS “may distract from other priorities,”79 it would not be surprising to find that their first response to hypotension when not using BIS is to reduce anesthetic dose, instead of iniating vasopressor polypharmacy. As such, even if the only benefit of using processed EEG measurement of anesthetic depth was to train anesthesiologists to avoid hypotension by keeping anesthetic depth on the light side, that would be sufficient justification to encourage its use. The Balanced Anesthesia Study may provide further insight into this issue.100

Be that as it may, whether the effect of lighter anesthesia is on mortality, morbidity, POCD, and/or delirium, a substantial and growing body of evidence indicates that, ceteris paribus, lighter is better than deeper.

Adjuvants, Diet, and Exercise

What about dexmedetomidine, statins and exercise?

Dexmedetomidine has been reported to reduce delirium compared with placebo, midazolam, or propofol sedation;101 increase survival rate in patients undergoing cardiac surgery;102 reduce delirium, ventilator time, tachycardia, and hypertension compared to midazolam in critically ill ICU patients; reduce focal neurological dysfunction during mild sedation in patients with supratentorial masses compared with midazolam and propofol; reduce early POCD and serum levels of Aβ and tau protein in orthotopic liver transplant patients; reduce ischemic brain injury,103 and improve cognitive function and quality of life in elderly noncardiac surgery patients.104 In contrast to those findings, Shehabi and colleagues did not find reduced mortality in a large sample of critically ill ICU patients sedated primarily with dexmedetomidine. Paradoxically, that study also found higher mortality in patients younger than the median age of the entire sample with lower mortality in patients older than the median age.105 A current review of dexmedetomidine’s benefits and drawbacks for neurosurgical patients is available from Lin et al.106

Blanco et al107 found that statin withdrawal increased the incidence of poor outcomes in ischemic stroke patients and retrospective reviews by Flint and colleagues found that statin use during hospitalization for ischemic stroke108 and after intracerebral hemorrhage109 is strongly associated with improved survival and discharge disposition, even for patients without prior statin use. Tsivgoulis et al110 found that statin pre-treatment in patients diagnosed with acute large artery atherosclerosis associates with neurological improvement and reduced stroke recurrence. Using a prospective design, Al-Khaled et al111 found that statin treatment reduced mortality 3 months after acute ischemic stroke, Zhang et al112 found enhanced recovery with increased brain-derived neurotrophic factor 2 months after ischemic stroke in patients who received atorvastatin, and Zheng and Chen113 found that adding the free radical scavenger edaravone to atorvastatin increased recovery 2 weeks poststroke. Lee and Xiang114 also found promising results for edaravone in cerebral infarction patients treated with ultra-early thrombolysis. Most recently, Mrkobrada et al115 found that covert stroke after noncardiac surgery is associated with both POD and POCD 1 year after surgery. It follows that if statins reduce the risk of stroke, they reduce the risk of POCD.

Pharmacological and mechanical approaches notwithstanding, perhaps early postoperative mobilization116 and age-appropriate exercise remains the best all-round regimen for both prevention and treatment of POCD.117,118


Reports of adverse effects of anesthetics on elderly patients appeared in 1955,4 so this problem and some of its potential solutions are not new, but our awareness of them has experienced a renaissance. That awareness has raised a new level of concern for patients over 60 exposed to general anesthesia for more than a brief period of time. Unless and until we are able to classify anesthetic neurotoxicity as a rare complication, the first-do-no-harm approach should: (1) add anesthesia to surgical intervention on the physiological cost side of the cost/benefit ratio when making decisions about whether and when to proceed with surgery; (2) minimize anesthetic depth and periods of EEG suppression; (3) limit the duration of continuous anesthesia whenever possible; (4) consider the possibility that regional anesthesia with deep sedation may be as neurotoxic as general anesthesia; and (5) when feasible, use regional anesthesia with light or no sedation.

At the very least, newfound concerns generated by available data should inspire a great deal of translational research. If that research is funded, our guess is that anesthetic, sedative, and adjuvant drugs will soon be ranked according to their safety profile, and augmentation of endogenous processes of repair and regeneration will deliver brain protection and recovery to the young as well as the old.119


1. Harrison AF, Shorter J. RNA-binding proteins with prion-like domains in health and disease. Biochem J. 2017;474:1417–1438.
2. Kline RP, Pirraglia E, Cheng H, et al. For the Alzheimerʼs Disease Neuro-imaging Initiative. Surgery and brain atrophy in cognitively normal elderly subjects and subjects diagnosed with mild cognitive impairment. Anesthesiology. 2012;116:603–612.
3. Silbert B, Evered L, Scott DA, et al. Preexisting cognitive impairment is associated with postoperative cognitive dysfunction after hip joint replacement surgery. Anesthesiology. 2015;122:1224–1234.
4. Bedford PD. Adverse cerebral effects of anaesthesia on old people. Lancet. 1955;269:259–263.
5. Moller JT, Cluitmans P, Rasmussen LS, et al. Long-term postoperative cognitive dysfunction in the elderly: ISPOCD1 study. Lancet. 1998;351:857–861; Erratum: Lancet. 1998;351(9117):1742.
6. Monk TG, Weldon BC, Garvan CW, et al. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology. 2008;108:18–30.
7. Monk TG, Saini V, Weldon BC, et al. Anesthetic management and one-year mortality after noncardiac surgery. Anesth Analg. 2005;100:4–10.
8. Steinmetz J, Christensen KB, Lund T, et al. And the ISPOCD Group. Long-term consequences of postoperative cognitive dysfunction. Anesthesiology. 2009;110:548–555.
9. Newman MF, Kirchner JL, Phillips-Bute B, et al. For the Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001;344:395–402; Erratum: N Engl J Med. 2001;344(24):1876.
10. Evered LA, Silbert BS, Scott DA, et al. Prevalence of dementia 7.5 years after coronary artery bypass graft surgery. Anesthesiology. 2016;125:62–71.
11. Grocott HP, Mackensen GB, Grigore AM, et al. And the Neurologic Outcome Research Group (NORG) and Cardiothoracic Anesthesiology Research Endeavors (CARE) Investigators of the Duke Heart Center. Postoperative hyperthermia is associated with cognitive dysfunction after coronary artery bypass graft surgery. Stroke. 2002;33:537–541.
12. Hofland J, Ouattara A, Fellahi JL, et al. For the Xenon-CABG Study Group. Effect of xenon anesthesia compared to sevoflurane and total intravenous anesthesia for coronary artery bypass graft surgery on postoperative cardiac troponin release: an international, multicenter, phase 3, single-blinded, randomized noninferiority trial. Anesthesiology. 2017;127:918–933.
13. Rylova A, Maze M. Protecting the brain with xenon anesthesia for neurosurgical procedures. J Neurosurg Anesiol. 2019;31:18–29.
14. Shroyer AL, Grover FL, Hattler B, et al. For the Veterans Affairs Randomized On/Off Bypass (ROOBY) Study Group. On-pump versus off-pump coronary artery bypass surgery. N Engl J Med. 2009;361:1827–1837.
15. Lamy A, Devereaux PJ, Prabhakaran D, et al. For the CORONARY Investigators. Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. N Engl J Med. 2013;368:1179–1188.
16. Diegeler A, Börgermann J, Kappert U, et al. For the GOPCABE Study Group. Off-pump versus on-pump coronary artery bypass grafting in elderly patients. N Engl J Med. 2013;368:1189–1198.
17. Kowalewski M, Pawliszak W, Malvindi PG, et al. Off-pump coronary artery bypass grafting improves short-term outcomes in high-risk patients compared with on-pump coronary artery bypass grafting: meta-analysis. J Thorac Cardiovasc Surg. 2016;151:60–77.e1–e58.
18. Lamy A, Devereaux PJ, Prabhakaran D, et al. For the CORONARY Investigators. Off-pump or on-pump coronary-artery bypass grafting at 30 days. N Engl J Med. 2012;366:1489–1497.
19. Hartung J, Cottrell JE. Intention-to-treat analysis should be supplemented by on-treatment analysis. J Neurosurg Anesthesiol. 2005;17:63–64.
20. Hartung J, Cottrell JE. Anesthesia and long-term major adverse cognitive effects: P values and confidence intervals based on nonrandom samples cannot justify acceptance of null hypotheses. J Neurosurg Anesthesiol. 2016;28:185–186.
21. Hartung J, Cottrell JE, Giffin JP. Absence of evidence is not evidence of absence. Anesthe-siology. 1983;58:298–300.
22. Puskas JD, Stringer A, Hwang SN, et al. Neuro-cognitive and neuroanatomic changes after off-pump versus on-pump coronary artery bypass grafting: long-term follow-up of a randomized trial. J Thorac Cardiovasc Surg. 2011;141:1116–1127.
23. Li Y, Dong H, Chen M, et al. Preconditioning with repeated hyper-baric oxygen induces myocardial and cerebral protection in patients undergoing coronary artery bypass graft surgery: a prospective, randomized, controlled clinical trial. J Cardiothorac Vasc Anesth. 2011;25:908–916.
24. Brewer R, Theurer PF, Cogan CM, et al. For the Membership of the Michigan Society of Thoracic and Cardiovascular Surgeons. Morbidity but not mortality is decreased after off-pump coronary artery bypass surgery. Ann Thorac Surg. 2014;97:831–836.
25. Kok WF, van Harten AE, Koene BM, et al. A pilot study of cerebral tissue oxygenation and postoperative cognitive dysfunction among patients undergoing coronary artery bypass grafting randomised to surgery with or without cardiopulmonary bypass. Anaesthesia. 2014;69:613–622.
26. Abu-Omar Y, Cader S, Guerrieri WL, et al. Short-term changes in cerebral activity in on-pump and off-pump cardiac surgery defined by functional magnetic resonance imaging and their relationship to microembolization. J Thorac Cardiovasc Surg. 2006;132:1119–1125.
27. Bucerius J, Gummert JF, Borger MA, et al. Predictors of delirium after cardiac surgery delirium: effect of beating-heart (off-pump) surgery. J Thorac Cardiovasc Surg. 2004;127:57–64.
28. Girard TD, Jackson JC, Pandharipande PP, et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med. 2010;38:1513–1520.
29. Morandi A, Rogers BP, Gunther ML, et al. The relationship between delirium duration, white matter integrity, and cognitive impairment in intensive care unit survivors as determined by diffusion tensor imaging: the VISIONS prospective cohort magnetic resonance imaging study. Crit Care Med. 2012;40:2182–2189.
30. Saczynski JS, Marcantonio ER, Quach L, et al. Cognitive trajectories after postoperative delirium. N Engl J Med. 2012;367:30–39.
31. Gross AL, Jones RN, Habtemariam DA, et al. Delirium and long-term cognitive trajectory among persons with dementia. Arch Intern Med. 2012;172:1324–1331.
32. Neufeld KJ, Leoutsakos JM, Sieber FE, et al. Outcomes of early delirium diagnosis after general anesthesia in the elderly. Anesth Analg. 2013;117:471–478.
33. Mangusan RF, Hooper V, Denslow SA, et al. Outcomes associated with postoperative delirium after cardiac surgery. Am J Crit Care. 2015;24:156–163.
34. Inouye SK, Marcantonio ER, Kosar CM, et al. The short-term and long-term relationship between delirium and cognitive trajectory in older surgical patients. J Alzheimers Dement. 2016;12:766–775.
35. Daiello LA, Racine AM, Gou RY, et al. Postoperative delirium and postoperative cognitive dysfunction. Anesthesiology. 2019;131:477–491.
36. Sprung J, Roberts RO, Weingarten TN, et al. Post-operative delirium in elderly patients is associated with subsequent cognitive impairment. Br J Anaesth. 2017;119:316–323.
37. Royse CF, Saager L, Whitlock R, et al. Impact of methylprednisolone on postoperative quality of recovery and delirium in the Steroids in Cardiac Surgery Trial: a randomized, double-blind, placebo-controlled sub-study. Anesthesiology. 2017;126:223–233.
38. Brown CH, Probert J, Healy R, et al. Cognitive decline after delirium in patients undergoing cardiac surgery. Anesthesiology. 2018;129:406–414.
39. Rindermann H, Neubauer AC. Processing speed, intelligence, creativity, and school performance. Intelligence. 2004;32:573–589.
40. Vasunilashorn SM, Fong TG, Albuquerque A, et al. Delirium severity post-surgery and its relationship with long-term cognitive decline in a cohort of patients without dementia. J Alzheimers Dis. 2018;61:347–358.
41. Rudolph JL, Marcantonio ER. Postoperative delirium: acute change with long-term implications. Anesth Analg. 2011;112:1202–1211.
42. Subramaniyan S, Terrando N. Neuroinflammation and perioperative neurocognitive disorders. Anesth Analg. 2019;128:781–788.
43. Saxena S, Lai IK, Li R, et al. Neuroinflammation is a putative target for prevention and treatment of perioperative neurocognitive disorders. Br Med Bull. 2019;130:125–135.
44. Vom Berg J, Prokop S, Miller KR, et al. Inhibition of IL-12/IL-23 signaling reduces Alzheimer’s disease-like pathology and cognitive decline. Nature Med. 2012;18:1812–1819.
45. Mathew JP, Podgoreanu MV, Grocott HP, et al. For the PEGASUS Investigative Team. Genetic variants in P-selectin and C-reactive protein influence susceptibility to cognitive decline after cardiac surgery. J Am Coll Cardiol. 2007;49:1934–1942.
46. Mathew JP, Rinder CS, Howe JG, et al. Platelet Pla2 polymorphism enhances risk of neurocognitive decline after cardiopulmonary bypass. Ann Thorac Surg. 2001;71:663–666.
47. Zhang B, Tian M, Zhen Y, et al. The effects of isoflurane and desflurane on cognitive function in humans. Anesth Analg. 2012;114:410–415.
48. Ishii K, Makita T, Yamashita H, et al. Total intravenous anesthesia with propofol is associated with a lower rate of postoperative delirium in comparison with sevoflurane anesthesia in elderly patients. J Clin Anesth. 2016;33:428–431.
49. Geng YJ, Wu QH, Zhang RQ. Effect of propofol, sevoflurane, and isoflurane on postoperative cognitive dysfunction following laparoscopic cholecystectomy in elderly patients: a randomized controlled trial. J Clin Anesth. 2017;38:165–171.
50. Crary JF, Shao CY, Mirra SS, et al. Atypical protein kinase C in neuro-degenerative disease I: PKMζ aggregates with limbic neurofibrillary tangles and AMPA recep-tors in Alzheimer disease. J Neuropathol Exp Neurol. 2006;65:319–326.
51. Tang J, Eckenhoff MF, Eckenhoff RG. Anesthesia and the old brain. Anesth Analg. 2010;110:421–426.
52. Larson ME, Lesné SE. Soluble Aβ oligomer production and toxicity. J Neurochem. 2012;120(suppl 1):125–139.
53. Larson ME, Sherman MA, Greimel S, et al. Soluble α-synuclein is a novel modulator of Alzheimer’s disease pathophysiology. J Neurosci. 2012;32:10253–10266.
54. Bianchi SL, Tran T, Liu C, et al. Brain and behavior changes in 12-month-old Tg2576 and nontransgenic mice exposed to anesthetics. Neurobiol Aging. 2008;29:1002–1010.
55. Dong Y, Zhang G, Zhang B, et al. The common inhalational anesthetic sevoflurane induces apoptosis and increases beta-amyloid protein levels. Arch Neurol. 2009;66:620–631.
56. Xie Z, Dong Y, Maeda U, et al. The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid beta-protein accumulation. J Neurosci. 2007;27:1247–1254.
57. Zhang B, Dong Y, Zhang G, et al. The inhalation anesthetic desflurane induces caspase activation and increases amyloid beta-protein levels under hypoxic conditions. J Biol Chem. 2008;283:11866–11875.
58. Zhang Y, Xu Z, Wang H, et al. Anesthetics isoflurane and desflurane differently affect mitochondrial function, learning, and memory. Ann Neurol. 2012;71:687–698.
59. Tang JX, Baranov D, Hammond M, et al. Human Alzheimer and inflammation biomarkers after anesthesia and surgery. Anesthesiology. 2011;115:727–732.
60. Wang J, Meng F, Cottrell JE, et al. Metabotropic actions of the volatile anaesthetic sevoflurane increase protein kinase Mζ synthesis and induce immediate preconditioning protection of rat hippocampal slices. J Physiol. 2012;590:4093–4107.
61. Palotás A, Reis HJ, Bogáts G, et al. Coronary artery bypass surgery provokes Alzheimer’s disease-like changes in the cerebrospinal fluid. J Alzheimers Dis. 2010;21:1153–1164.
62. Cottrell JE, Hartung J. Developmental disability in the young and postoperative cognitive dysfunction in the elderly after anesthesia and surgery: do data justify changing clinical practice? Mt Sinai J Med. 2012;79:75–94.
63. Chen PL, Yang CW, Tseng YK, et al. Risk of dementia after anaesthesia and surgery. Br J Psychiatry. 2014;204:188–193.
64. Chen CW, Lin CC, Chen KB, et al. Increased risk of dementia in people with previous exposure to general anesthesia: a nationwide population-based case-control study. Alzheimers Dement. 2014;10:196–204.
65. Bellou V, Belbasis L, Tzoulaki I, et al. Systematic evaluation of the associations between environmental risk factors and dementia: an umbrella review of systematic reviews and meta-analyses. Alzheimers Dement. 2017;13:406–418.
66. Purro SA, Farrow MA, Linehan J, et al. Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone. Nature. 2018;564:415–419.
67. Jaunmuktane Z, Quaegebeur A, Taipa R, et al. Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery. Acta Neuropathol. 2018;135:671–679.
68. Brown CH IV, Azman AS, Gottschalk A, et al. Sedation depth during spinal anesthesia and survival in elderly patients undergoing hip fracture repair. Anesth Analg. 2014;118:977–980.
69. Ancelin ML, de Roquefeuil G, Ledésert B, et al. Exposure to anaesthetic agents, cognitive functioning and depressive symptomatology in the elderly. Br J Psychiatry. 2001;178:360–366.
70. Sieber FE, Zakriya KJ, Gottschalk A, et al. Sedation depth during spinal anesthesia and the development of postoperative delirium in elderly patients undergoing hip fracture repair. Mayo Clin Proc. 2010;85:18–26; Erratum: Mayo Clin Proc. 2010;85(4):400.
71. Sieber FE, Neufeld KJ, Gottschalk A, et al. Effect of depth of sedation in older patients undergoing hip fracture repair on postoperative delirium. JAMA Surg. 2018;564:415–419.
72. Ballard C, Jones E, Gauge N, et al. Optimised anaesthesia to reduce post operative cognitive decline (POCD) in older patients undergoing elective surgery, a randomized controlled trial. PLoS One. 2012;7:e37410.
73. Chan MT, Cheng BC, Lee TM, et al. And the CODA Trial Group. BIS-guided anesthesia decreases postoperative delirium and cognitive decline. J Neurosurg Anesthesiol. 2013;25:33–42.
74. Fritz BA, Kalarickal PL, Maybrier HR, et al. Intraoperative electro-encephalogram suppression predicts postoperative delirium. Anesth Analg. 2016;122:234–242.
75. Fritz BA, Maybrier HR, Avidan MS. Intraoperative electroencephalogram suppression at lower volatile anesthetic concentrations predicts postoperative delirium occurring in the intensive care unit. Br J anaesth. 2018;121:241–248.
76. Punjasawadwong Y, Chau-In W, Laopaiboon M, et al. Processed electroencephalogram and evoked potential techniques for amelioration of postoperative delirium and cognitive dysfunction following non-cardiac and non-neurosurgical procedures in adults. Chochran Database Stst Rev. 2018;5:CD011283.
77. MacKenzie KK, Britt-Spells AM, Sands LP, et al. Processed electroencephalogram monitoring and postoperative delirium: a systematic review and meta-analysis. Anesthesiology. 2018;129:417–427.
78. Green D, Ballard C, Kunst G. Depth of anaesthesia optimisation and postoperative cognitive dysfunction. Br J Anaesth. 2015;114:343–344.
79. Wildes TS, Mickle AM, Ben Abdallah A, et al. ENGAGES Research Group. Effect of electroencephalography-guided anesthetic administration on postoperative delirium among older adults undergoing major surgery: the ENGAGES randomized clinical trial. JAMA. 2019;321:473–483.
80. Hartung J, Cottrell JE. Against dissing BIS. BJA. 2019. [Epub ahead of print].
81. Howell DC: Bootstrapping medians. 2015. Available at: Accessed July 1, 2019.
82. Motulsky H. The Mann-Whitney test doesn’t really compare medians. Available at: Accessed July 1, 2019.
83. Leslie K, Myles PS, Forbes A, et al. The effect of bispectral index monitoring on long-term survival in the B-aware trial. Anesth Analg. 2010;110:816–822.
84. Ackland GL, Pryor KO. Electroencephalography-guided anaesthetic administration does not impact postoperative delirium among older adults undergoing major surgery: an independent discussion of the ENGAGES trial. Br J Anaesth. 2019;123:112–117.
85. Boyer L. Man vs. machine: the latest chapter is just starting. 2018. Available at: Accessed July 1, 2019.
86. Scarlett J, Hahn N, Jacobsohn E, et al. The evidence that deep anesthesia impacts long term mortality is not compelling. Anesth Analg. 2005;101:1880–1881.
87. Avidan MS, Zhang L, Burnside BA, et al. Anesthesia awareness and bispectral index. N Engl J Med. 2008;358:1097–1108.
88. Bottros MM, Palanca BJ, Mashour GA, et al. Estimation of the bispectral index by anesthesiologists: an inverse turing test. Anesthesiology. 2011;114:1093–1101.
89. Kertai MD, Palanca BJ, Pal N, et al. Bispectral index monitoring, duration of bispectral index below 45, patient risk factors, and intermediate-term mortality after noncardiac surgery in the B-unaware trial. Anesthesiology. 2011;114:545–556.
90. Avidan MS, Jacobsohn E, Glick D, et al. Prevention of intraoperative awareness in a high-risk surgical population. N Engl J Med. 2011;363:591–600.
91. Whitlock EL, Villafranca AJ, Lin N, et al. Relationship between bispectral index values and volatile anesthetic concentrations during the maintenance phase of anesthesia in the b-unaware trial. Anesthesiology. 2011;115:1209–1218.
92. Zolyomi A, Gerstein NS, Petersen TR. To the editor (letter). JAMA. 2019;321:2470.
93. Avidan MS, Wildes TS. Power of negative thinking. Brit J Anaesth. 2015;114:3–5.
94. EEG guidance of anesthesia (ENGAGES-CANADA) (ENGAGES). website. 2016. Available at: Accessed July 20, 2019.
95. Abbott TEF, Pearse RM. Depth of anesthesia and postoperative delirium. JAMA. 2019;321:459–460.
96. Abbott TEF, Pearse RM, Archbold RA, et al. A prospective international multicenter cohort study of intraoperative heart rate and systolic blood pressure and myocardial injury after non cardiac surgery: results of the VISION study. Anesth Analg. 2018;126:1936–1945.
97. Abbott TE, Ackland GL, Archbold RA, et al. Preoperative heart rate and myocardial injury after non-cardiac surgery: results of a predefined secondary analysis of the VISION study. Br J Anaesth. 2016;117:172–181.
98. Monk TG, Weldon BC. Anesthetic depth is a predictor of mortality: it’s time to take the next step. Anesthesiology. 2010;112:1070–1072.
99. Desai V, Chan PH, Prentice HA, et al. Is anesthesia technique associated with higher risk of mortality or complications within 90 days of surgery for geriatric patients with hip fractures? Clin Orthop Relat Res. 2018;476:1178–1188.
100. Short TG. Balanced Anesthesia Study. Oral presentation at the ANCZA Meeting, April, 2019 (written report pending). 2019. Available at: Accessed July 1, 2019.
101. Duan X, Coburn M, Rossaint R, et al. Efficacy of perioperative dexmedetomidine on postoperative delirium: systematic review and meta-analysis with trial sequential analysis of randomized controlled trials. Br J Anaesth. 2018;121:384–397.
102. Peng K, Ji FH, Liu HY, et al. Effects of perioperative dexmedetomidine on postoperative mortality and morbidity: a systematic review and meta-analysis. Clin Ther. 2019;41:138–154.
103. Jiang L, Hu M, Lu Y, et al. The protective effects of dexmedetomidine on ischemic brain injury: a meta-analysis. J Clin Anesth. 2017;40:25–32.
104. Zhang DF, Su X, Meng ZT, et al. Impact of dexmedetomidine on long-term outcomes after noncardiac surgery in elderly: 3-year follow-up of a randomized controlled trial. Ann Surg. 2019;270:356–363.
105. Shehabi Y, Howe BD, Bellomo R, et al. Early sedation with dexmedetomidine in critically ill patients. N Engl J Med. 2019;380:2506–2517.
106. Lin N, Vutskits L, Bebawy JF, et al. Perspectives on dexmedetomidine use for neurosurgical patients. J Neurosurg Anesthes. 2018. [Epub ahead of print].
107. Blanco M, Nombela F, Castellanos M, et al. Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology. 2007;69:904–910.
108. Flint AC, Kamel H, Navi BB, et al. Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival. Stroke. 2012;43:147–154.
109. Flint AC, Conell C, Rao VA, et al. Effect of statin use during hospitalization for intracerebral hemorrhage on mortality and discharge disposition. JAMA Neurol. 2014;71:1364–1371.
110. Tsivgoulis G, Katsanos AH, Sharma VK, et al. Statin pretreatment is associated with better outcomes in large artery atherosclerotic stroke. Neurology. 2016;86:1103–1111.
111. Al-Khaled M, Matthis C, Eggers J. Statin treatment in patients with acute ischemic stroke. Int J Stroke. 2014;9:597–601.
112. Zhang J, Mu X, Breker DA, et al. Atorvastatin treatment is associated with increased BDNF level and improved functional recovery after atherothrombotic stroke. Int J Neurosci. 2017;127:92–97.
113. Zheng J, Chen X. Edaravone offers neuroprotection for acute diabetic stroke patients. Ir J Med Sci. 2016;185:819–824.
114. Lee XR, Xiang GL. Effects of edaravone, the free radical scavenger, on outcomes in acute cerebral infarction patients treated with ultra-early thrombolysis of recombinant tissue plasminogen activator. Clin Neurol Neurosurg. 2018;167:157–161.
115. Mrkobrada M, Chan MT, Cowan D, et al. Covert stroke after noncardiac surgery is associated with cognitive decline: NeuroVISION Study. Lancet. 2019. [Epub ahead of print].
116. Chen CC, Li HC, Liang JT, et al. Effect of a modified hospital elder life program on delirium and length of hospital stay in patients undergoing abdominal surgery: a cluster randomized clinical trial. JAMA Surg. 2017;152:827–834.
117. Moran J, Guinan E, McCormic P, et al. The ability of prehabilitation to influence postoperative outcome after intra-abdominal operation: a systematic review and meta-analysis. Surgery. 2016;160:1189–1201.
118. Northey JM, Cherbuin N, Pumpa KL, et al. Exercise interventions for cognitive function in adults older than 50: a systematic review with meta-analysis. Br J Sports Med. 2018;52:154–160.
119. Cottrell J. We care, therefore we are: anesthesia-related morbidity and mortality: the 46th Rovenstine Lecture. Anesthesiology. 2008;109:377–388.

Alzheimer disease; anesthetic depth; anesthetic neurotoxicity; bispectral index; cardiopulmonary bypass; elderly patients; postoperative cognitive dysfunction; postoperative delirium

Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc